Pharmaceutical sciences faculty awarded patents

Two members of The University of North Texas Health Science Center at Fort Worth’s College of Pharmacy faculty have made significant strides in their respective fields. Dr. Kyle Emmitte, an expert in medicinal chemistry, and Dr. Jin Liu, specializing in computational drug design, joined forces on a project which showed potential in treating certain types of cancer. Their efforts culminated in a patent approval, validating the efficacy of their computational approach in molecular design.

To complete their work, they also worked alongside former faculty member Jack Wang, a renowned cancer biologist. Through a meticulous process combining wet lab chemistry with molecular modeling, they designed novel molecules with the potential to hinder cancer progression. After rigorous testing and validation, their findings were published in the prestigious British Journal of Cancer.

Heads UpReflecting on the significance of their work, Emmitte emphasized the journey from discovery to patent issuance.

“The project that led to this patent is a great example of the power of interdisciplinary team science,” Emmitte said. “Quite simply, none of us could have reached the end goal of the project without relying on each other’s unique skill sets and contributions.”

While the publication marked a milestone, obtaining a patent signifies the recognition of their novel discoveries and the potential intellectual property they represent. It’s a testament to their commitment to pushing boundaries and translating scientific breakthroughs into tangible solutions.

Liujin Lab PageDr. Jin Liu has another patent approved for the improved CRISPR-Cas9 technology for genome editing. Both patents hold immense promise for the future of health care. Emmitte and Liu’s innovations pave the way for novel therapeutic interventions, offering hope for patients battling cancer and genetic diseases. The potential impact extends beyond academic accolades and provides promise for those in need of better treatment options.

“These patents not only embody years of hard work and dedication, but also hold the promise of revolutionizing treatment for genetic disorders,” Liu said. “The potential to cure diseases like cancer, sickle cell anemia and possibly even HIV is profoundly motivating.”

Recent News

A6db708d 247f 429b 8828 578ae70ec5eb
  • Our People
|May 16, 2024

Inspirational students part of HSC’s Class of 2024

A former Fort Worth tactical medic, a first-generation college student graduating as an osteopathic physician, a labor and delivery nurse, and a couple becoming physical therapists together are just a few of the inspirational students who will walk the stage during HSC’s commencement ceremony on W...
Img 4034
  • Our People
|May 16, 2024

Association of Schools and Programs of Public Health brings inaugural community outreach event to HSC campus

On May 8, the School of Public Health at The University of North Texas Health Science Center at Fort Worth, collaborated with the Association of Schools and Programs of Public Health to bring public health advocates together both virtually and in-person. The event, titled “Framing the Future...
2780b0a9 4611 4003 B866 657551d3b26f
  • Our People
|May 15, 2024

Faculty highlight: Dr. Jehad Alzyoud

Dr. Alzyoud is an assistant professor within The University of Health Science Center at Fort Worth’s Department of Physical Therapy. He teaches the neurological rehabilitation course series. “My research is focused on understanding human balance, particularly how sitting balance impairment foll...
Karen Middle
  • Our People
|May 15, 2024

Personalized Health and Well-Being graduate pivots to altruistic career path

Karen Smith was walking around the American College of Lifestyle Medicine’s annual conference in 2022 in Orlando, Florida, when she came across The University of North Texas Health Science Center at Fort Worth’s booth. Smith, a registered dietician for almost 20 years, had already decided she wa...